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doi:10.1016/j.ejvs.2011.08.004Abstract Background: Timing of surgery remains a controversial subject with some concerns
persisting that the benefit of early carotid endarterectomy (CEA) offsets the perioperative
risks. We investigated the neurological outcome of patients with symptomatic internal carotid
artery (ICA) stenosis after surgery in relation to the timing of treatment.
Methods: From January 2005 to June 2010, 468 patients (nZ 349 male, 74.6%, median age 71
years) underwent CEA for symptomatic stenosis. Perioperative morbidity and mortality rates
were assessed in the 30 days’ follow-up.
Results: The median time interval between index event and CEA was 7 days; the overall stroke
and death rate reached 3.4%. There was no difference in the 30 days’ rate of stroke /death
rate, depending on the timing of surgery (n Z 5/241, 2.1% in patients treated within 1 week
vs. n Z 10/215, 4.7% in patients treated thereafter, p Z 0.12). Patients with a postoperative
neurological deterioration had more often an ischaemic infarction on preoperative cerebral
computed tomography (CCT) compared with those without deterioration (n Z 6/15, 40.0%
vs. nZ 39/441, 9.0%, pZ 0.003). Logistic regression analysis showed that patients with preop-
erative infarction on CCT had the highest risk for postoperative neurological deterioration.
Conclusion: An infarction on the preoperative CCT leads to an increased risk for a postopera-
tive deterioration after CEA. Patients should be treated at an early point in time with bland
CCTs.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.-med.ac.at (B. Rantner).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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11 In addition, cerebral diagnostics was performedstandard in the treatment of symptomatic carotid artery
stenosis, given a perioperative stroke and death rate of
<6%. It is widely accepted that CEA is most beneficial if it
is performed within 2 weeks of the index symptom and
many professional societies have changed their guidelines
regarding this new timeframe.1e4 However, there is still
evidence of significant delays within national audits.
Halliday et al. reported that in the UK, only 20% of
symptomatic patients had surgery within the targeted 2
weeks.5 Any delay is associated with an increased risk of
a second disabling or fatal stroke in the waiting period.
There are various factors identifying patients at high risk
for a recurrent ischaemic event.6 Morphological factors,
such as plaque surface and ischaemic area in the cerebral
computed tomography (CCT), as well as gender, age and
contralateral pathology have an influence on the course
and risk of recurrence of ischaemic events after an
ischaemic index event.7e10 The aims of the article at hand
were two issues.
(1) What is the neurological outcome of patients treated
early by CEA after the index event?
(2) Which risk factors are associated with postoperative
neurological deterioration after early CEA?Methods
Patient selection
We evaluated the data of all patients consecutively treated
for a symptomatic carotid artery stenosis between January
2005 and June 2010. Patients with a severe stenosis of at
least 50% of the internal carotid artery and symptoms
(transient ischaemic attacks (TIAs), amaurosis fugax and
stroke) that originated from the carotid artery stenosis
within the last 6 months were included in the data analysis.
Five patients who had symptoms more than 6 months prior
to the surgery were excluded. In four patients with bilateral
symptomatic stenosis and separate treatment on the two
sides, we randomly chose sides for statistical analysis.
Another three patients who were allocated from another
hospital were excluded from analysis because of incom-
plete data about the time point and the character of the
ischaemic event.
Baseline investigation
Demographic and morphological data were assessed from
all patients. The patients were admitted to a stroke unit
and neurological status was available for all patients at
admission. Neurological symptoms were classified as TIA,
amaurosis fugax and stroke. In addition, neurological
function and severity of impairment was measured using
the modified Rankin scale. The Rankin classification was
applied for all patients by a single experienced neurologist.
All patients had ultrasound scanning for the calculation of
the degree of carotid artery stenosis, according to Grey
Scale and Doppler US Criteria for Diagnosis of ICAeither by CCT with a contrast medium or by magnetic
resonance imaging (MRI), depending on the renal function.
The aims of neuroimaging were (1) to rule out haemor-
rhage, (2) to demonstrate the presence of ischaemia and
(3) to show the presence of haemodynamically compro-
mised tissue as tissue at risk or penumbra. We classified
CCT findings into five groups according to the state and
severity of ischaemia: (1) no ischaemia, (2) old infarction:
scar, decreased attenuation due to missing perfusion, (3)
oedema: earliest stage of brain damage with decreased
perifocal attenuation, (4) leaking bloodebrain barrier:
diffuse accumulation of contrast medium indicating the loss
of integrity of the bloodebrain barrier and (5) recent
infarction: defined area with decreased cerebral blood
flow. Vascular autoregulation is the mechanism by which
regional cerebral blood flow is maintained. In case of
cerebral ischaemia, the perfusion pressure is decreased,
which results in a prolongation of the blood transit time in
both areas, the ischaemic core and the penumbra. In the
penumbral tissue and not in the infarct core, the process of
autoregulation induces dilation of capillaries with an
attempt to maintain a constant blood flow. However, in the
infarct core, autoregulation mechanisms are overwhelmed
and the blood flow diminishes.12 CT scans were routinely
done at admission. In case of postponed surgery, cerebral
diagnostics was repeated the night before surgery. The
latest CCT scan was used for the statistical risk analysis. All
CCTs were assessed by a single experienced radiologist, and
the size of infarction was measured. In case of MRI diag-
nostics, patients were excluded from the study because of
varying sensitivity and specificity to detect a cerebral
ischaemia compared with a CCT.
The final decision towards surgery and the timing of
surgery was made in an interdisciplinary conference
between neurologists, interventional radiologists and
vascular surgeons, considering the severity of the clinical
neurological deficit and the stage of brain damage in the
CCT of the patient.
Six surgeons performed CEAs during the study period.
All CEAs were carried out under general anaesthesia.
Heparin (5000 IU) was administered intravenously before
cross clamping. Anti-platelet therapy was not stopped
perioperatively. Intra-operative angiography was routinely
done, except in patients with severe renal function
impairment.Postoperative investigations
Matters of interest in the 30-day follow-up period were ipsi-
and contralateral ischaemic events, myocardial infarction
and death from any cause. On the 2nd or 3rd postoperative
day, an ultrasound scanning of the internal carotid artery
and a neurological status of the patients were performed. If
the patients showed new neurological symptoms, the
neurological examination was repeated at once. Patients
with hyperperfusion were kept as inpatients for at least 7
days, with repeated ultrasound investigation and tight
control of the blood pressure.
A periprocedural stroke was clinically defined as an
increase on the Rankin scale of at least 1 point. In case of
734 B. Rantner et al.a neurological deterioration or varying neurological symp-
toms, the cerebral imaging was repeated.Statistical analysis
Comparisons of variables were performed using non-
parametric Wilcoxon rank sum tests, and Pearson’s c2-test
was appropriate. Variables contributing to the final neuro-
logical complication status were identified by multiple
logistic regression analysis.
Statistical analyses were performed with the Statistical
Package for Social Sciences for Windows (SPSS, Chicago, IL,
USA) version 18.0.Figure 1 Median time interval between onset of symptoms
and treatment, depending on the character of symptoms
(whiskers refer to 95% CI).Results
A total of 468 patients (nZ 349 male, 74.6%, median age 71
years) underwent CEA during the observation period for
neurological symptoms. All CEAs were primary and origi-
nated from atherosclerotic plaques. The majority of
patients showed up with TIAs and amaurosis fugax
(n Z 302, 64.5%), the severity of functional impairment
(measured by the modified Rankin scale) was according to
that (modified Rankins scale 2: n Z 424, 90.6%). The
mean delay between latest CCT, used for analysis, and
treatment was 2.5 days; the median interval was 1 day in
the overall study population. The overall perioperative 30
days’ stroke and death rate among patients was 3.4%
(n Z 15 second ischaemic events, one death). One patient
with an initial TIA, who was treated 2 days after the onset
of symptoms, died on postoperative day 10 due to an
intracerebral haemorrhage after hyperperfusion syndrome.
We did not find any myocardial infarction among our study
population, and no contralateral cerebral ischaemic events
were observed. CCT findings in patients with postoperative
neurological deterioration were as follows: in four cases
(26.7%), we saw a haemorrhage in the postoperative CCT,
nine patients (60%) experienced an ischaemic infarction.
Two patients (13.3%) remained without new cerebral
lesions in the CCT despite new neurological symptoms. We
observed one asymptomatic new infarction in a patient
where CCT was repeated because of suspected intracranial
vessel stenosis. The median delay between index event and
surgery was 7 days in the overall study population. After
dividing patients according to the neurological index event
(TIA, amaurosis fugax and stroke), we saw that the median
interval of onset of symptoms and treatment did not
extremely differ in these groups (Fig. 1). To keep statistical
power, we used the overall median delay as cut-off value
for further analyses. Table 1a summarises patient charac-
teristics divided into two time groups and shows that
patients with strokes and conformable Rankin scores were
predominantly treated more than 1 week after the index
event. In accordance with that, we saw that patients
treated in the later time period demonstrated pathological
findings more frequently in the CCT. In case of preoperative
cerebral infarction, lesion size was larger in the delayed
treatment group (13.0 vs. 24.1 mm, p Z 0.002). Morpho-
logical and technical data were comparable between the
two groups.Neurological outcome of patients treated rapidly
after the index event
There was no significant difference in postoperative stroke
rates in the early compared with the delayed group (Table
1b). The early treatment group even showed a lower rate of
perioperative complications (n Z 5/241, 2.1% in the early
treatment group vs. nZ 10/215, 4.7% in the delayed group,
p Z 0.12).
Risk factors for a postoperative neurological
deterioration after early CEA
There was no significant difference in the mode of
presentation between patients who experienced a post-
operative deterioration and those without worsening
(Table 2). We saw a statistically significant difference,
however, concerning pathological findings in the CCTs
(summed up in three groups) in patients with periproce-
dural neurological deterioration compared with those
without deterioration (Table 2). Size of preoperative
infarction was comparable in both groups (Table 2).
Table 3a shows the association of the clinical neurological
deficit assessed by the Rankin scale and the morphological
brain damage in the CCT before treatment. Table 3b addi-
tionally shows the association between CCT findings and the
character of the qualifying neurological event at admission.
This showed that at least 3.3% of patients with a mild
neurological defect (TIA and amaurosis fugax) already
showed signs of a cerebral infarction in the CT diagnostics.
Age, gender, American Society of Anesthesiologists (ASA)
score, timing of surgery and CCT findings before surgery
were considered as most important factors contributing to
the neurological course of patients. The multiple logistic
regression analysis was accordingly adjusted and showed
that the CCT before surgery was the strongest predictor of
the postoperative outcome. In a first step, we performed
the regression analysis with CCT findings (divided in five
groups) as continuous parameter, according to the state of
Table 1a Demographic and technical data of the study population stratified according to the timing of surgery (0e7 days vs.
8e174 days).
0e7 days
n Z 245
8e174 days
n Z 223
P
Age, yrs 70.2  9.7 68.8  9.4 0.08
Gender: male/female, n (%) 181/64 (73.9/26.1) 168/55 (75.3/24.7) 0.72
Modified Rankin scale 2 vs. >2, n (%) 232/9 (96.3/3.7) 192/23 (89.3/10.7) 0.004
ASA 1/2 vs. 3/4, n (%) 71/170 (29.5/70.5) 73/140 (34.3/65.7) 0.27
Anti-platelet/Coumarine therapy, n (%) 144/245 (58.7) 138/223 (61.9) 0.44
Symptoms at admission
TIA, n (%) 122 (50.4) 75 (33.6) <0.001
Amaurosis, n (%) 56 (23.1) 49 (22.0)
Stroke, n (%) 64 (26.5) 99 (44.4)
Degree of stenosis
50e69%, n (%) 29 (11.8) 38 (17.1) 0.05
70e90%, n (%) 181 (73.9) 141 (63.5)
>90%, n (%) 35 (14.3) 43 (19.4)
Degree of contralateral stenosis
<50%, n (%) 156 (63.7) 156 (70.0) 0.68
50e70%, n (%) 59 (24.1) 43 (19.3)
75e90%, n (%) 17 (6.9) 14 (6.3)
>90%, n (%) 3 (1.2) 3 (1.3)
Occlusion, n (%) 10 (4.1) 7 (3.1)
Procedure
CEA plus patch, n (%) 178 (72.7) 165 (74.0) 0.86
Eversion endarterectomy, n (%) 64 (26.1) 53 (23.8)
Others, n (%) 3 (1.2) 5 (2.2)
Shunt:
yes/no, n (%)
200/43 (82.3/17.7) 172/47 (78.5/21.5) 0.31
CCT before treatment
No pathological findings, n (%) 188 (77.0) 136 (61.2) 0.003
Edema, n (%) 1 (0.4) 3 (1.4)
Leaking bloodebrain barrier, n (%) 7 (2.9) 17 (7.6)
Recent infarction, n (%) 18 (7.4) 28 (12.6)
Old infarction, n (%) 25 (10.2) 35 (15.8)
Size of preoperative infarction (mm) 13.0  7.0 24.1  13.4 0.002
Data are provided as mean  SD if not indicated otherwise.
Data concerning the timing of surgery and the modified Rankin scale are available in 456 individuals, for ASA (American Society of
Anesthesiology) at admission in 454, for symptoms at admission in 465, for degree of stenosis in 467, for use of shunt in 462, and for CCT
a in 466 individuals. Size of infarction is available in 44 individuals with a recent infarction.
Table 1b Neurological outcome of the study population
stratified according to the timing of surgery (0e7 days vs.
8e174 days).
0e7 days
n Z 241
8e174 days
n Z 215
P
Neurological outcome postoperativea
No deterioration, n (%) 236 (97.9) 205 (95.3) 0.12
Rankin þ 1, n (%) 5 (2.1) 10 (4.7)
a Data for the neurological perioperative outcome and the
timing of surgery are available in 456 individuals.
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deterioration was 1.71 (95% confidence interval (CI)
1.26e2.31, p Z 0.001) for each state of ischaemia
(Table 4a). Thereafter, we summed up the early stages of
brain damage (oedema and leaking bloodebrain barrier)
and compared it with the situation of a recent infarction.
We saw a significant difference in this model. Signs of an
infarction increased the probability for a neurological
deterioration 7.6 fold. Surgery was not risky in the early
stages of brain damage, however (Table 4b). Timing of
surgery and the co-morbidities of the patients (measured
by the ASA classification) did not influence the outcome in
either model (Tables 4a and 4b).
Discussion
Our study revealed that early surgery after an ischaemic
index event is safe and effective in stroke therapy. Itseems that a severe clinical neurological deficit does not
contraindicate early treatment. In case of a recent
infarction in the CCT, surgery should be postponed,
however.
Table 2 Comparison of the initial neurological impairment and CCT findings at admission between patients without a peri-
operative neurological deterioration and those with neurological deterioration.
No deterioration
n Z 441
Deterioration (modified Rankin scale þ 1)
n Z 15
P
Neurological symptoms at admissiona
Rankin 0e2, n (%) 411 (93.2) 13 (86.7) 0.28
Rankin 3, n (%) 30 (6.8) 2 (13.3)
CCT before treatmentb
No pathological findings, old infarction, n (%) 366 (84.7) 8 (53.3) 0.003
Oedema, leaking bloodebrain barrier n (%) 27 (6.3) 1 (6.7.)
Recent infarction, n (%) 39 (9.0) 6 (40.0)
Size of infarction, mmc 19.7  12.7 19.0  12.7 0.90
a Data for the neurological symptoms at admission and the perioperative outcome are available in 456 individuals.
b Data for CCT at admission and the perioperative outcome are available in 447 individuals.
c Size of infarction (provided as mean  standard deviation) is available in 43 individuals with a recent infarction.
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after the index event
A reanalysis of the pooled data of the North American
Symptomatic Carotid Endarterectomy Trial (NASCET) and
the European Carotid Surgery Trial (ECST) revealed that
surgery was most effective after an ischaemic stroke in
patients who were treated within the first 2 weeks, with
a rapid decline of the benefit thereafter, especially in
women.13,14 The diminishing benefit originates from the
early risk of a recurrent ischaemic event after the index
event, in particular after a TIA or a minor stroke. The 30-
day risk of a re-stroke is four to six times higher than
initially reported in literature, with the highest risk in the
first 7 days.15 Rothwell et al. report in their review of 2416
patients with ischaemic stroke that one-quarter of
patients experienced a preceding TIA. About 17% of those
TIAs occurred on the same day, 9% occurred on the day
before the stroke and 43% of overall TIAs happened within
1 week before stroke onset.16 In a recently published
series, Ois and colleagues present data of a neurologic
recurrence of 20.9% within 72 h, 6.7% for the first week
and 3.7% for the second week.17 In our study population,
we did not find recurrent ischaemic events in patients
awaiting surgery. Several studies have recently demon-
strated the safety of performing CEA at an early point in
time after the start of neurological symptoms. The peri-
operative morbidity and mortality rates are comparable
with those for delayed surgery in otherwise stable
patients.18e25 Naylor has suggested that early CEA
prevents more strokes than the delayed surgery, evenTable 3a Association of the clinical neurological deficit at adm
CCT before treatmenta
No pathological findings, old infarction, n (%) n Z 374
Oedema, leaking bloodebrain barrier, n (%) n Z 28
Recent infarction, n (%) n Z 45
a Data for CCT at admission and Rankin at admission are available iwith higher perioperative stroke rates than would nor-
mally be accepted.26 Salem and co-workers recently
published data of 108 consecutive patients with symp-
tomatic internal carotid artery stenosis focussing on the
30-day outcomes. They saw a perioperative 30-day death/
stroke rate of 2.4% in patients treated within 14 days of
the index event, increasing to 4.3% in patients undergoing
surgery within 7 days. The authors conclude from their
data that, in the hyperacute phase, CEA can safely be
performed without significantly increasing the perioper-
ative risk.27 We could confirm this with the data at hand.
Treatment within the first 7 days after the index ischae-
mic event showed good perioperative outcomes for the
patients in our study population.
Risk factors for a postoperative neurological
deterioration after early CEA
Amongst several single-centre observations, Paty et al.
presented a retrospective series of 228 patients with CEA
performed within 1e4 weeks after an ischaemic stroke. The
reported permanent perioperative neurological deficit
ranged between 2.8% and 3.4% equally among the four time
groups (1e4 weeks).28 With the data at hand, we confirmed
our own data from a publication in 2006 where we already
observed that the perioperative neurological outcome did
not depend on the timing of surgery.23 Bond published
a systematic review in 4278 patients with minor stroke who
had CEA, either early (<3e6 weeks) or delayed (>3e6
weeks). This review showed no higher risk of stroke with
early treatment in stable patients. The authors found noission and the CCT findings at admission in three groups.
Rankin at admission P
Rankin 0e2 Rankin 3
360 (96.3) 14 (3.7) <0.001
24 (85.7) 4 (14.3)
32 (71.1) 13 (28.9)
n 447 individuals.
Table 3b Association of the character of the neurological deficit (TIA and AF vs. stroke) at admission and the CCT findings at
admission in three groups.
Character of symptoms at admission P
TIA/AFb Stroke
CCT before treatmenta
No pathological findings, old infarction, n (%) n Z 381 281 (94.0) 100 (64.1) <0.001
Oedema, leaking bloodebrain barrier, n (%) n Z 28 8 (2.7) 20 (12.8)
Recent infarction, n (%) n Z 46 10 (3.3) 36 (23.1)
a Data for CCT at admission and character of symptoms at admission are available in 455 individuals.
b TIA: Transient ischaemic attack, AF: Amaurosis fugax.
Table 4a Multiple logistic regression analysis for variables
contributing to a perioperative neurological deterioration
(CCT as continuous variable, 0e5, increasing severity of
brain damage).
Variable (increment) OR (95% CI) P
Age (1 yr) 1.01 (0.96e1.07) 0.63
Gender 0.73 (0.20e2.69) 0.63
Timing of surgery (7 days
vs. >7days)
1.80 (0.58e5.58) 0.31
CCT before treatment
(per group)a
1.65 (1.21e2.24) 0.001
ASA at admission (1 point) 0.67 (0.24e1.84) 0.43
a Group: 0: no ischaemia, 1: old infarction, 2: oedema, 3:
leaking blood brain barrier, 4: recent infarction.
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23 studies.29 These results are in agreement with data from
Capoccia et al., who report in their retrospective series of
62 patients that a severe neurological deficit (measured
using the National Institutes of Health Stroke Scale (NIHSS)
score) does not contraindicate early surgery.30 The initial
neurological deficit did also not influence the further
course of the patients in our study population.
The risk of haemorrhagic transformation of the ischaemic
area after a stroke is a matter of major concern in stroke
therapy. The rate of conversion might be reassuringly low in
literature, however.15,26 Our data indicate that the risk of an
intracranial haemorrhage or cerebral re-infarction with an
impairment of the neurological function is highest inTable 4b Multiple logistic regression analysis for variables con
before treatment in groups: comparing oedema and leaking blood
bland CCTs).
Variable (increment)
Age (1 yr)
Gender
Timing of surgery (7 days vs. >7days)
CCT before treatment
Edema þ leaking bloodebrain barrier vs. no pathological findings
Recent infarction vs. no pathological findings þ old infarction
ASA at admission (1 point)patients with pre-existing morphological signs of cerebral
infarctions. We found a significant increase for a neurolog-
ical deterioration of at least one point on the Rankin scale in
case of a cerebral infarction before surgery in the CCT. Early
signs of cerebral damage (oedema) in the CCT and even
a leaking bloodebrain barrier were not hazardous for
surgery. Paty et al. described similar results in their study.
Moreover, they described that an increasing lesion size on
the preoperative CCT scan increased the odds of a perma-
nent neurological deficit by 1.7 (95% CI 1.1e2.8, p Z 0.03)
per centimetre of diameter.28 The lesion size was of no
relevance in our investigation, certainly due to the small
number of patients. Other factors, such as the number of co-
morbidities, measured by the ASA classification, or the
timing of surgery, were not contributing to a perioperative
neurological deterioration.
In clinical practice, CCT scanning is not consistently
performed in patients with TIA or amaurosis fugax. Our data
show that clinical symptoms do not strongly correlate with
the morphological findings in the CCT (Tables 3a and 3b):
64% of our patients with clinical strokes had bland CCTs; on
the other hand, 3.3% of patients presenting with TIAs or an
episode of amaurosis fugax already had signs of an infarc-
tion in the CCT before surgery. This implicates to perform
cerebral diagnostics in any case, even if patients show up
with moderate neurological symptoms.
The main limitation of this study is the retrospective
design. Complete data collection was not possible, as
patients were also allocated from other hospitals. Besides
that, we had little numbers of perioperative complications.
This restricted statistical analysis. It might have been
reasonable to divide the study population into two groups,tributing to a perioperative neurological deterioration (CCT
barrier with bland CCTs and comparing recent infarctions with
OR (95% CI) P
1.02 (0.96e1.07) 0.61
0.77 (0.21e2.86) 0.70
1.98 (0.64e6.12) 0.24
þ old infarction 1.51 (0.18e12.85) 0.71
6.83 (2.14e21.77) 0.001
0.66 (0.24e1.82) 0.42
738 B. Rantner et al.according to the qualifying neurological event (TIA and
amaurosis fugax vs. stroke), to appropriately picture the
severity of the disease. However, with a total of 15 peri-
operative neurological events we lose power for calcula-
tions in the subgroups. We conclude from the data at hand
that further studies are necessary to define best treatment
strategies for patients with recent infarction in the CCT.
The fact that ischaemic events predominantly recur within
the first 7e14 days after a qualifying index event makes the
decision to postpone surgery extremely difficult. The
benefit of early treatment needs to be weighed with the
risk of a postoperative intracerebral haemorrhage in these
patients in a larger cohort.
This is, to our knowledge, the largest single-centre
series from patients with symptomatic carotid artery
stenosis and early treatment within 1 week after the index
event. Our data support the concept of early CEA in the
daily routine. CEA can safely be performed in the majority
of patients. It should be discussed, however, to postpone
surgery in patients with severe morphological defects as
signs of acute infarction in the neuroimaging, or even
better, treat patients at an early point in time without
relevant cerebral lesions.Conflict of Interest
None.Funding
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